Alterity Therapeutics Limited (ATHE)

Alterity Therapeutics Revenue

In the fiscal year ending June 30, 2025, Alterity Therapeutics had annual revenue of 5.44M AUD with 35.32% growth. Alterity Therapeutics had revenue of 3.83M in the half year ending June 30, 2025, with 150.44% growth.

• Revenue (ttm): 5.44M AUD
• Revenue Growth: +35.32%
• P/S Ratio: 21.99
• Revenue / Employee: 604,324 AUD
• Employees: 9
• Market Cap: 78.41M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	5.44M	1.42M	35.32%
Jun 30, 2024	4.02M	102.95K	2.63%
Jun 30, 2023	3.92M	-1.21M	-23.56%
Jun 30, 2022	5.12M	783.93K	18.06%
Jun 30, 2021	4.34M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.